Avidity Biosciences, Inc.
NASDAQ:RNA
50.36 (USD) • At close September 5, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 10.897 | 9.56 | 9.224 | 9.326 | 6.787 | 2.319 | 0.379 |
| Kosten van de omzet
| 2.776 | 2.101 | 1.387 | 0.639 | 37.602 | 14.539 | 8.436 |
| Brutowinst
| 10.897 | 7.459 | 7.837 | 8.687 | -30.815 | -12.22 | -8.057 |
| Brutowinstmarge
| 1 | 0.78 | 0.85 | 0.931 | -4.54 | -5.27 | -21.259 |
| Onderzoek- en ontwikkelingskosten
| 303.593 | 190.968 | 150.404 | 101.182 | 37.602 | 14.539 | 8.436 |
| Algemene en administratieve kosten
| 86.24 | 54.19 | 37.733 | 26.195 | 13.462 | 5.112 | 2.441 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 86.24 | 54.19 | 37.733 | 26.195 | 13.462 | 5.112 | 2.441 |
| Overige kosten
| 0 | -2.101 | -1.387 | -0.639 | -37.602 | 0 | 0 |
| Bedrijfskosten
| 389.833 | 243.057 | 186.75 | 126.738 | 13.462 | 19.651 | 10.877 |
| Bedrijfsresultaat
| -378.936 | -235.598 | -178.913 | -118.051 | -44.277 | -17.332 | -10.498 |
| Bedrijfsresultaat ratio
| -34.774 | -24.644 | -19.396 | -12.658 | -6.524 | -7.474 | -27.699 |
| Totaal overige inkomsten en kosten netto
| 56.634 | 23.378 | 4.918 | 0.042 | -0.078 | -7.402 | -0.718 |
| Inkomen voor belasting
| -322.302 | -212.22 | -173.995 | -118.009 | -44.355 | -24.734 | -11.216 |
| Inkomen voor belasting ratio
| -29.577 | -22.199 | -18.863 | -12.654 | -6.535 | -10.666 | -29.594 |
| Belastingkosten
| 0 | 0 | -4.918 | -0.639 | 0 | 7.387 | 0.718 |
| Nettowinst
| -322.302 | -212.22 | -173.995 | -118.009 | -44.355 | -24.734 | -11.934 |
| Nettowinstmarge
| -29.577 | -22.199 | -18.863 | -12.654 | -6.535 | -10.666 | -31.488 |
| WPA (Winst Per Aandeel)
| -2.89 | -2.91 | -3.34 | -2.85 | -2.05 | -0.86 | -0.58 |
| Verwaterde WPA
| -2.89 | -2.91 | -3.34 | -2.85 | -2.05 | -0.86 | -0.58 |
| EBITDA
| -376.16 | -233.497 | -177.526 | -117.412 | -43.773 | -16.75 | -10.115 |
| EBITDA ratio
| -34.52 | -24.424 | -19.246 | -12.59 | -6.45 | -7.223 | -26.689 |